SummerHaven Investment Management LLC bought a new stake in Varex Imaging (NASDAQ:VREX – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 99,431 shares of the company’s stock, valued at approximately $1,233,000. Varex Imaging accounts for approximately 0.7% of SummerHaven Investment Management LLC’s portfolio, making the stock its 7th biggest holding. SummerHaven Investment Management LLC owned 0.24% of Varex Imaging as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also modified their holdings of the company. Empowered Funds LLC boosted its position in Varex Imaging by 7.3% during the first quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock worth $2,078,000 after purchasing an additional 12,151 shares in the last quarter. Jane Street Group LLC raised its stake in shares of Varex Imaging by 17.9% during the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock worth $1,849,000 after buying an additional 24,160 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Varex Imaging by 25.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 13,104 shares of the company’s stock worth $115,000 after buying an additional 2,659 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Varex Imaging by 0.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 2,788,092 shares of the company’s stock valued at $23,894,000 after acquiring an additional 8,680 shares during the last quarter. Finally, Pzena Investment Management LLC increased its holdings in Varex Imaging by 11.6% during the 2nd quarter. Pzena Investment Management LLC now owns 4,244,977 shares of the company’s stock valued at $36,804,000 after acquiring an additional 442,628 shares in the last quarter.
Analysts Set New Price Targets
Several analysts have issued reports on VREX shares. Wall Street Zen raised shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 22nd. Oppenheimer reduced their target price on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. B. Riley reiterated a “buy” rating and set a $16.00 target price on shares of Varex Imaging in a report on Wednesday, November 19th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $17.00.
Varex Imaging Price Performance
VREX stock opened at $14.08 on Wednesday. The stock has a market capitalization of $590.23 million, a price-to-earnings ratio of -8.28 and a beta of 0.86. The company has a quick ratio of 1.83, a current ratio of 3.43 and a debt-to-equity ratio of 0.75. Varex Imaging has a 52-week low of $6.76 and a 52-week high of $15.46. The stock’s fifty day simple moving average is $12.26 and its 200-day simple moving average is $11.30.
Varex Imaging (NASDAQ:VREX – Get Free Report) last released its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.19. The firm had revenue of $228.90 million for the quarter, compared to the consensus estimate of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Equities research analysts expect that Varex Imaging will post 0.53 EPS for the current year.
Varex Imaging Profile
Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.
The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.
Further Reading
- Five stocks we like better than Varex Imaging
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Nvidia’s 3 Secret Partners
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
